文献速递前列腺癌

mpMRI时代的前列腺活检策略:综合综述

Biopsy strategies in the era of mpMRI: a comprehensive review.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-09-04

该叙述性综述于2024年2月15日检索Medline、Web of Science和Google Scholar,讨论mpMRI时代前列腺活检策略。经会阴途径被国际指南推荐,因减少尿脓毒症;系统活检可检出5-16%的MRI靶向活检单独会漏诊的临床显著前列腺癌。

要点

  • 经会阴途径被国际指南推荐,因术后脓毒症率低于经直肠途径。
  • 系统活检可检出5-16%的MRI靶向活检单独会漏诊的临床显著前列腺癌。
  • MRI系统性低估病灶大小,周围活检可提高敏感性但增加穿刺针数。

核心结论

  • 多种活检策略已被描述,在评估适合局灶治疗的患者时应了解这些策略。
  • 由于MRI系统性低估病灶大小,系统活检尤其是周围活检可提高敏感性,但代价是穿刺针数增加。

研究设计与样本

  • 叙述性综述,于2024年2月15日使用Medline、Web of Science和Google Scholar进行非系统性文献检索。

主要发现

  • 经直肠途径与术后脓毒症率增加相关,即使给予充分抗生素预防。
  • 经会阴途径被国际指南推荐,首先因其尿脓毒症率降低。
  • 近期证据显示经会阴途径非劣于经直肠途径,且在前列腺前部和尖部区域临床显著前列腺癌检出率更高。
  • 认知融合、软件融合或磁共振腔内靶向等多种靶向技术可提高对前列腺癌侵袭性和负荷的准确风险评估,同时减少穿刺针数和临床不显著前列腺癌数量。
  • MRI靶向活检作用已证实,但系统活检仍重要,因其检出5-16%的MRI靶向活检单独会漏诊的临床显著前列腺癌。

关键数值与推荐

  • mpMRI检测指数病灶的敏感性超过90%。
  • 系统活检检出5-16%的临床显著前列腺癌是MRI靶向活检单独会漏诊的。
  • 系统活检策略主要取决于途径(经直肠 vs 经会阴)和穿刺针数(10-12针 vs 饱和活检 vs 经会阴模板定位活检或Ginsburg方案 vs 区域活检)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since its initial description the prostate biopsy technique for detection of prostate cancer (PCA) has constantly evolved. Multiparametric magnetic resonance imaging (mpMRI) has been proven to have a sensitivity exceeding 90% to detect the index lesion. This narrative review discusses the evidence around several biopsy strategies, especially in the context of patients that might be eligible for focal therapy. METHOD: A non-systematic literature research was performed on February 15th 2024 using the Medical Literature Analysis and Retrieval System Online (Medline), Web of Science and Google Scholar. RESULTS: The transrectal (TR) route is associated with an increased postoperative sepsis rate, even with adequate antibiotic prophylaxis. The transperineal (TP) route is now recommended by international guidelines, firstly for its decreased rate of urosepsis. Recent evidence shows a non-inferiority of TP compared to TR route, and even a higher detection rate of clinically significant PCA (csPCA) in the anterior and apical region, that are usually difficult to target using the TR route. Several targeting techniques (cognitive, software-fusion or in-bore) enhance our ability to provide an accurate risk assessment of prostate cancer aggressiveness and burden, while reducing the number of cores and reducing the number of clinically insignificant prostate cancer (ciPCA). While MRI-TB have proven their role, the role of systematic biopsies (SB) is still important because it detects 5-16% of csPCA that would have been missed by MRI-TB alone. The strategies of SB depend mainly on the route used (TR vs. TP) and the number of cores to be collected (10-12 cores vs. saturation biopsies vs. trans-perineal template mapping-biopsies or Ginsburg Protocol vs. regional biopsies). CONCLUSION: Several biopsy strategies have been described and should be known when assessing patients for focal therapy. Because MRI systematically under evaluates the lesion size, systematic biopsies, and especially perilesional biopsies, can help to increase sensitivity at the cost of an increased number of cores.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Windisch O, Valerio M, Yee CH, et al. Biopsy strategies in the era of mpMRI: a comprehensive review. Prostate Cancer Prostatic Dis. 2024. PMID: 39232094. doi:10.1038/s41391-024-00884-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。